{"date":"2026-11-11","count":79,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6703-2026-11-11-2031-1h3ceio","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"20:31:45","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-11-11 20:31，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-11-11-1942-z2kzlb","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"19:42:47","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-11-11 19:42，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-11-11-1839-1jhyk7o","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:39:55","subject":"公告本公司董事會通過與某台灣生技股份有限公司簽署藥物合作開發協議","clause":"第10款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-11-11 18:39，「公告本公司董事會通過與某台灣生技股份有限公司簽署藥物合作開發協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-11-11-1839-1s5ilpi","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:39:37","subject":"公告本公司因會計師事務所內部調整更換會計師","clause":"第7款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-11-11 18:39，「公告本公司因會計師事務所內部調整更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-11-11-1838-z2kzlb","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:38:52","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-11-11 18:38，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-11-11-1830-31gzb0","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:30:21","subject":"一一五年第三季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-11-11 18:30，「一一五年第三季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-11-11-1824-1jhyk7o","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:24:03","subject":"公告本公司董事會通過與某台灣生技股份有限公司簽署藥物合作開發協議","clause":"第10款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-11-11 18:24，「公告本公司董事會通過與某台灣生技股份有限公司簽署藥物合作開發協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-11-11-1823-5rh607","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:23:42","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-11-11 18:23，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-11-11-1823-1joelrw","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"18:23:19","subject":"公告本公司董事會決議通過115年第3季財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-11-11 18:23，「公告本公司董事會決議通過115年第3季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-11-11-1814-17hxk3d","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"18:14:58","subject":"本公司董事會通過解除經理人競業禁止之限制案","clause":"第21款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-11-11 18:14，「本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-11-11-1814-1gwtp8p","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"18:14:26","subject":"公告本公司董事會通過115年度第三季合併財務報表","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-11-11 18:14，「公告本公司董事會通過115年度第三季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-11-11-1801-1v20vp9","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"18:01:51","subject":"公告本公司董事會決議辦理現金增資發行新股案","clause":"第9款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-11-11 18:01，「公告本公司董事會決議辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-11-11-1746-1o7iiyg","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:46:06","subject":"說明本公司線上商店平台委外服務廠商資安事件","clause":"第26款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-11-11 17:46，「說明本公司線上商店平台委外服務廠商資安事件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-11-11-1743-z2kzlb","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:43:10","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-11-11 17:43，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-11-11-1743-lkwcc1","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:43:03","subject":"公告本公司董事會補選薪資報酬委員會委員","clause":"第6款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-11-11 17:43，「公告本公司董事會補選薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-11-11-1739-ygkpln","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:39:14","subject":"公告本公司董事會通過副總經理任命案","clause":"第8款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-11-11 17:39，「公告本公司董事會通過副總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-11-11-1738-17ezlvn","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:38:12","subject":"公告本公司董事會通過115年度第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-11-11 17:38，「公告本公司董事會通過115年度第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-11-11-1733-1thbs85","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:33:17","subject":"公告本公司董事會通過115年度第3季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-11-11 17:33，「公告本公司董事會通過115年度第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-11-11-1729-1al4pcd","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"17:29:00","subject":"公告本公司薪資報酬委員會成員異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-11-11 17:29，「公告本公司薪資報酬委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-11-11-1728-182acdw","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"17:28:00","subject":"公告本公司董事會決議通過一一五年第三季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-11-11 17:28，「公告本公司董事會決議通過一一五年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-11-11-1728-p12is9","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:28:00","subject":"公告本公司公司治理主管委任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-11-11 17:28，「公告本公司公司治理主管委任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-11-11-1722-17m4wqc","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:22:00","subject":"公告本公司民國115年度第三季合併財務報告業經提報董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-11-11 17:22，「公告本公司民國115年度第三季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-11-11-1713-ag0ktz","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:13:00","subject":"本公司受邀參加永豐金證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-11-11 17:13，「本公司受邀參加永豐金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-11-11-1707-p67uuk","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"17:07:00","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-11-11 17:07，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-11-11-1707-yohk44","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"17:07:00","subject":"代重要子公司SYNCHEALTH LTD.公告內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-11-11 17:07，「代重要子公司SYNCHEALTH LTD.公告內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-11-11-1705-103mbhh","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:05:27","subject":"公告本公司董事會決議通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-11-11 17:05，「公告本公司董事會決議通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-11-11-1705-tiu8dd","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:05:06","subject":"公告本公司董事會通過115年第3季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-11-11 17:05，「公告本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-11-11-1705-17up2wc","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:05:00","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"第11款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-11-11 17:05，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6431-2026-11-11-1703-z2kzlb","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"17:03:00","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-11-11 17:03，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-11-11-1702-cihc0g","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:02:10","subject":"公告本公司董事會決議通過現金增資子公司生立生物科技股份有限公司","clause":"第20款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-11-11 17:02，「公告本公司董事會決議通過現金增資子公司生立生物科技股份有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-11-11-1700-8zjb11","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"17:00:16","subject":"代子公司生立生物科技(股)公司公告董事會決議辦理現金增資發行新股","clause":"第11款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-11-11 17:00，「代子公司生立生物科技(股)公司公告董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-11-11-1659-1fwi4nw","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:59:49","subject":"公告本公司及子公司生立生物科技(股)公司與台灣糖業(股)公司簽署合作協議書","clause":"第10款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-11-11 16:59，「公告本公司及子公司生立生物科技(股)公司與台灣糖業(股)公司簽署合作協議書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-11-11-1658-z2kzlb","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"16:58:55","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-11-11 16:58，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-11-11-1657-ymouvi","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"16:57:37","subject":"本公司董事會決議與美吾華(股)公司之產品代理銷售合約屆期不續","clause":"第25款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-11-11 16:57，「本公司董事會決議與美吾華(股)公司之產品代理銷售合約屆期不續」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-11-11-1655-rfwdba","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"16:55:10","subject":"更正子公司115年10月衍生性商品交易資訊","clause":"第51款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-11-11 16:55，「更正子公司115年10月衍生性商品交易資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-11-11-1650-8h1mcf","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"16:50:09","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款應公告事項","clause":"第22款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-11-11 16:50，「本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款應公告事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-11-11-1643-1kj5pdo","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:43:59","subject":"公告本公司115年度第3季合併財務報告經董事會通過","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-11-11 16:43，「公告本公司115年度第3季合併財務報告經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-11-11-1643-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:43:02","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-11-11 16:43，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-11-11-1642-svdi6j","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:42:24","subject":"本公司董事會決議股利分派及資本公積發放現金","clause":"第14款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-11-11 16:42，「本公司董事會決議股利分派及資本公積發放現金」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-11-11-1639-1xummcg","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:39:07","subject":"公告本公司董事會提報民國115年第三季合併財務報表","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-11-11 16:39，「公告本公司董事會提報民國115年第三季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-11-11-1634-c0r2vi","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"16:34:49","subject":"更正公告本公司115年10月營收變化原因說明","clause":"第44款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-11-11 16:34，「更正公告本公司115年10月營收變化原因說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-11-11-1632-z2kzlb","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:32:00","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-11-11 16:32，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-11-11-1631-1up9jb5","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"16:31:00","subject":"公告本公司115年第三季財務報表已提報董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-11-11 16:31，「公告本公司115年第三季財務報表已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-11-11-1630-tugflv","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:30:00","subject":"本公司因配合會計師事務所內部調整更換會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-11-11 16:30，「本公司因配合會計師事務所內部調整更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-11-11-1617-1x4a6gz","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"16:17:00","subject":"本公司受邀參加由永豐金證券匯立分公司舉辦之CLST Taiwan Market Mover Access Day","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-11-11 16:17，「本公司受邀參加由永豐金證券匯立分公司舉辦之CLST Taiwan Market Mover Access Day」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-11-11-1605-cvgmep","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:05:36","subject":"本公司董事會決議員工認股權憑證轉發行新股之增資基準日","clause":"第11款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-11-11 16:05，「本公司董事會決議員工認股權憑證轉發行新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-11-11-1605-li9lxd","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:05:13","subject":"子公司新增資金貸與符合資金貸與及背書保證處理準則第22條第1項第3款情事","clause":"第23款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-11-11 16:05，「子公司新增資金貸與符合資金貸與及背書保證處理準則第22條第1項第3款情事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-11-11-1604-zub84j","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:04:43","subject":"本公司董事會決議第4次買回庫藏股","clause":"第35款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-11-11 16:04，「本公司董事會決議第4次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-11-11-1604-75zahb","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:04:09","subject":"本公司董事會通過115年第3季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-11-11 16:04，「本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-11-11-1602-1nnt8f1","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:02:46","subject":"公告本公司董事會通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-11-11 16:02，「公告本公司董事會通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-11-11-1600-z2kzlb","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"16:00:01","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-11-11 16:00，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-11-11-1540-4jkijl","company_id":"6467","company":"泰合","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:40:21","subject":"公告本公司新藥TAH3311取得以色列「APIXABAN FILMPRODUCT AND USES THEREOF」發明專利","clause":"第51款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-11-11 15:40，「公告本公司新藥TAH3311取得以色列「APIXABAN FILMPRODUCT AND USES THEREOF」發明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-11-11-1538-tiu8dd","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"15:38:28","subject":"公告本公司董事會通過115年第3季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-11-11 15:38，「公告本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-11-11-1530-294stw","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:30:17","subject":"公告本公司受凱基證券邀請參加線上會議說明營運概況。","clause":"第12款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-11-11 15:30，「公告本公司受凱基證券邀請參加線上會議說明營運概況。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-11-11-1527-h4v2ei","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:27:11","subject":"本公司董事會通過115年第三季財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-11-11 15:27，「本公司董事會通過115年第三季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-11-11-1526-qyn9co","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:26:50","subject":"本公司董事會決議註銷庫藏股及訂定減資基準日","clause":"第11款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-11-11 15:26，「本公司董事會決議註銷庫藏股及訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-11-11-1513-1s7xzm3","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:13:28","subject":"公告本公司向關係人取得使用權資產","clause":"第20款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-11-11 15:13，「公告本公司向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-11-11-1513-1th6xb","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:13:04","subject":"公告本公司向關係人處分使用權資產","clause":"第20款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-11-11 15:13，「公告本公司向關係人處分使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-11-11-1512-19lwnw5","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:12:32","subject":"本公司董事會決議分派115年第三季盈餘","clause":"第14款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-11-11 15:12，「本公司董事會決議分派115年第三季盈餘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-11-11-1512-z2kzlb","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:12:07","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-11-11 15:12，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-11-11-1507-z2kzlb","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-11-11","time":"15:07:00","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第43款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-11-11 15:07，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-11-1500-tjxx6d","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"15:00:00","subject":"本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額","clause":"第11款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-11 15:00，「本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-11-1459-1ll5vp9","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:59:30","subject":"本公司董事會決議115年度第1次限制員工權利新股發行及增資基準日","clause":"第51款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-11 14:59，「本公司董事會決議115年度第1次限制員工權利新股發行及增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-11-1458-bhf0ul","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:58:31","subject":"本公司董事會決議與臨床CRO等公司簽訂EG12184產品臨床一期試驗委託研究案","clause":"第51款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-11 14:58，「本公司董事會決議與臨床CRO等公司簽訂EG12184產品臨床一期試驗委託研究案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-11-1457-ukonnt","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:57:42","subject":"本公司民國115年第三季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-11 14:57，「本公司民國115年第三季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-11-1457-c6ibsk","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:57:07","subject":"公告本公司董事會通過設置永續長","clause":"第8款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-11 14:57，「公告本公司董事會通過設置永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-11-1455-40o515","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:55:20","subject":"公告本公司董事會通過「公司治理委員會」更名為「公司治理及提名暨永續發展委員會」","clause":"第6款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-11 14:55，「公告本公司董事會通過「公司治理委員會」更名為「公司治理及提名暨永續發展委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-11-11-1454-enqq2p","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:54:37","subject":"公告本公司受邀參加第一金證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-11-25","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-11-11 14:54，「公告本公司受邀參加第一金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-11-11-1453-1okcz5i","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:53:39","subject":"公告本公司115年第三季合併財務報告提報董事會","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-11-11 14:53，「公告本公司115年第三季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6446-2026-11-11-1440-bcvs5j","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:40:37","subject":"本公司代子公司FORUS Therapeutics Inc.公告向加拿大衛生部申請新藥BESREMi新增適應症，新增適應症為原發性血小板過多症（ET）","clause":"第10款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-11-11 14:40，「本公司代子公司FORUS Therapeutics Inc.公告向加拿大衛生部申請新藥BESREMi新增適應症，新增適應」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-11-11-1435-1nnt8f1","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:35:43","subject":"公告本公司董事會通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-11-11 14:35，「公告本公司董事會通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-11-11-1435-z2kzlb","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:35:26","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-11-11 14:35，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-11-11-1422-p67uuk","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"14:22:30","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-11-11 14:22，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-11-11-1420-691dvn","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"14:20:05","subject":"公告本公司董事會決議通過115年第3季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-11-11 14:20，「公告本公司董事會決議通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-11-11-1418-tiu8dd","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:18:48","subject":"公告本公司董事會通過115年第3季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-11-11 14:18，「公告本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-11-11-1413-1k7ww0w","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-11-11","time":"14:13:08","subject":"本公司董事會決議與懷特生技新藥(股)公司之代理銷售合約屆期不續","clause":"第25款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-11-11 14:13，「本公司董事會決議與懷特生技新藥(股)公司之代理銷售合約屆期不續」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-11-11-1349-17ezlvn","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"13:49:12","subject":"公告本公司董事會通過115年度第三季合併財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-11-11 13:49，「公告本公司董事會通過115年度第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-11-11-1347-ke9rob","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"13:47:15","subject":"公告本公司董事會通過115年第3季合併財務報表","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-11-11 13:47，「公告本公司董事會通過115年第3季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-11-11-0800-1y8d9lf","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-11-11","time":"08:00:17","subject":"中裕新藥長效愛滋新藥TMB-365/TMB-380臨床研究成果榮登國際頂尖醫學期刊《The Lancet HIV》","clause":"第53款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-11-11 08:00，「中裕新藥長效愛滋新藥TMB-365/TMB-380臨床研究成果榮登國際頂尖醫學期刊《The Lancet HIV》」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}